Key statistics
As of last trade, aTyr Pharma Inc (471A:FRA) traded at 0.64, 36.75% above the 52 week low of 0.468 set on Jan 29, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.64 |
|---|---|
| High | 0.64 |
| Low | 0.64 |
| Bid | 0.65 |
| Offer | 0.785 |
| Previous close | 0.655 |
| Average volume | 9.69k |
|---|---|
| Shares outstanding | 97.99m |
| Free float | 96.58m |
| P/E (TTM) | -- |
| Market cap | 86.23m USD |
| EPS (TTM) | -0.8345 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 07:05 GMT.
More ▼
Announcements
- aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
- aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
- aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results
- aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
